Loading...
 
Toggle Health Problems and D

COVID death 5.2X more likely if Vitamin D deficient – May 2022


25-hydroxyvitamin D is a predictor of COVID-19 severity of hospitalized patients

P:OS X https://doi.org/10.1371/journal.pone.0268038
Nguyen N. Nguyen ,Muppala N. P. Raju,Briget da Graca,Dapeng Wang,Nada A. Mohamed,Manohar B. Mutnal,Arundhati Rao,Monica Bennett,Matthew Gokingco,Huy Pham,Amin A. Mohammad

Image
Objectives
Studies investigating the association between vitamin D and severity of COVID-19 have mixed results perhaps due to immunoassay assessment of total 25-hydroxyvitamin D (tD) (the sum of 25-hydroxyvitamin-D2 [25-OH-D2] and 25-hydroxyvitamin-D3 [25-OH-D3]). Liquid chromatography tandem mass spectrometry (LC-MS/MS) has high analytical specificity and sensitivity for 25-OH-D2 and 25-OH-D3, and thus enables a more accurate assessment of impact on COVID-19 outcomes.

Methods
We established reference intervals for 25-OH-D3 and tD using LC-MS/MS. 25-OH-D2, 25-OH-D3 and tD were quantitated for 88 COVID-19 positive and 122 COVID-19 negative specimens. Chi-square or Fisher’s exact tests were used to test associations in binary variables. T-Tests or Wilcoxon rank sum tests were used for continuous variables. Cox proportional hazards were used to test associations between 25-OH-D3 or tD levels and length of stay (LOS). For mortality and ventilation, logistic regression models were used.

Results
COVID-19 patients with deficient (<20 ng/mL) levels of 25-OH-D3 had significantly longer LOS by 15.3 days. COVID-19 P patients with deficient (<20 ng/mL) and insufficient (<30 ng/mL) of tD had significantly longer LOS by 12.1 and 8.2 days, respectively.
Patients with insufficient levels of tD had significantly longer LOS by 13.7 days. COVID-19 patients with deficient serum 25-OH-D3 levels had significantly increased risk-adjusted odds of in-hospital mortality (OR [95% CI]: 5.29[1.53–18.24]); those with insufficient 25-OH-D3 had significantly increased risk for requiring ventilation during hospitalization was found at LCMS insufficient cutoff (OR [95% CI]: 2.75 [1.10–6.90]).

Conclusions
There is an inverse relationship of 25-hydroxyvitamin D levels and hospital LOS for COVID-19 patients. Vitamin D status is a predictor for severity of outcomes. LCMS results are useful for assessing the odds of mortality and the need for ventilation during hospitalization.
 Download the PDF from VitaminDWiki


VitaminDWiki - 50 studies in both categories Virus and Mortality

This list is automatically updated


VitaminDWiki – COVID-19 treated by Vitamin D - studies, reports, videos

As of Nov 25, 2022, the VitaminDWiki COVID page had:  19 trial results,   37 meta-analyses and reviews,   Mortality studies   see related:   Governments,   HealthProblems,   Hospitals,  Dark Skins,   26 risk factors are ALL associated with low Vit D,   Recent Virus pages   Fight COVID-19 with 50K Vit D weekly   Vaccines   Take lots of Vitamin D at first signs of COVID   116 COVID Clinical Trials using Vitamin D (08/2022)
5 most-recently changed Virus entries



Created by admin. Last Modification: Wednesday May 4, 2022 01:00:22 GMT-0000 by admin. (Version 3)

Attached files

ID Name Comment Uploaded Size Downloads
17546 Probability of continued hospitalization.jpg admin 04 May, 2022 00:54 38.93 Kb 148
17545 D predeict COVId severity.pdf PDF 2022 admin 04 May, 2022 00:53 782.47 Kb 54
See any problem with this page? Report it (WORKS NOV 2021)